Cargando…
Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate
INTRODUCTION: Folate receptor (FR)-expressing macrophages have been shown to accumulate at sites of inflammation, where they promote development of inflammatory symptoms. To target such a macrophage population, we designed and evaluated the biologic activity of EC0746, a novel folic acid conjugate o...
Autores principales: | Lu, Yingjuan, Stinnette, Torian W, Westrick, Elaine, Klein, Patrick J, Gehrke, Mark A, Cross, Vicky A, Vlahov, Iontcho R, Low, Philip S, Leamon, Christopher P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132048/ https://www.ncbi.nlm.nih.gov/pubmed/21463515 http://dx.doi.org/10.1186/ar3304 |
Ejemplares similares
-
Targeting folate receptor beta on monocytes/macrophages renders rapid inflammation resolution independent of root causes
por: Lu, Yingjuan J., et al.
Publicado: (2021) -
Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis
por: Elo, Petri, et al.
Publicado: (2021) -
Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent
por: Reddy, Joseph A., et al.
Publicado: (2020) -
The first achievement of complete remission in childhood leukemia by treatment with the folic acid antagonist aminopterin
por: Izraeli, Shai
Publicado: (2022) -
Import of a DHFR hybrid protein into glycosomes in vivo is not inhibited by the folate-analogue aminopterin
Publicado: (1996)